BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6083926)

  • 41. [Fibrinolytic activity and tissue plasminogen activator level in healthy individuals prior to and after a ten-minute venous stasis].
    Kubicka A; Libura M; Sacha T; Swadźba J; Undas A; Wandzilak M
    Pol Tyg Lek; 1993 Feb 1-8; 48(5-6):116-9. PubMed ID: 8361905
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prophylactic antithrombotic therapy with stanozolol in patients with familial antithrombin III deficiency.
    Winter JH; Fenech A; Bennett B; Douglas AS
    Br J Haematol; 1984 Jul; 57(3):527-37. PubMed ID: 6743570
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prevention of fibrinolytic shut-down after major surgery by intramuscular stanozolol.
    Blamey SL; McArdle BM; Burns P; Lowe GD; Forbes CD; Carter DC; Prentice CR
    Thromb Res; 1983 Aug; 31(3):451-9. PubMed ID: 20218001
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Stimulation of fibrinolytic activity in human skin fibroblasts by prostaglandins E1, E2 and I2.
    Crutchley DJ; Conanan LB; Maynard JR
    J Pharmacol Exp Ther; 1982 Sep; 222(3):544-9. PubMed ID: 7050342
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Effects of glycuronyl-glycosaminoglycan sulfate (3GS) on the fibrinolytic process in rabbits].
    Cavallini L; Lucchetti G; Li Calzi MA
    Clin Ter; 1978 Nov; 87(4):347-59. PubMed ID: 751764
    [No Abstract]   [Full Text] [Related]  

  • 46. Plasma fibrinolytic capacity in renal transplant recipients: effect of steroid-free immunosuppression therapy.
    Sartori MT; Rigotti P; Marchini F; Spiezia L; Baldan N; Furian L; Varvarikis C; Girolami A
    Transplantation; 2003 Apr; 75(7):994-8. PubMed ID: 12698086
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Turnover of tissue plasminogen activator in man.
    Matsuo O
    Thromb Haemost; 1982 Oct; 48(2):242. PubMed ID: 6891108
    [No Abstract]   [Full Text] [Related]  

  • 48. Staphylokinase reduces plasmin formation by endogenous plasminogen activators.
    Jin T; Bokarewa M; Zhu Y; Tarkowski A
    Eur J Haematol; 2008 Jul; 81(1):8-17. PubMed ID: 18331597
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of growth hormone on fibrinolytic system in rat.
    Bubber P; Singh KP; Arora S; Bansal DD
    Indian J Exp Biol; 1998 May; 36(5):514-6. PubMed ID: 9717468
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [State of the fibrinolytic and kinin systems of the blood after physical loading].
    Andreenko GV; Liutova LV; Beniumova OE
    Fiziol Zh SSSR Im I M Sechenova; 1980 Oct; 66(10):1473-80. PubMed ID: 7192224
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Oral stanozolol: effects on plasma and saliva fibrinolysis and plasma viscosity in normal males.
    Small M; McArdle BM; Lowe GD; Brodie MJ; Forbes CD; Prentice CR
    Thromb Res; 1983 Jul; 31(2):233-7. PubMed ID: 6685353
    [No Abstract]   [Full Text] [Related]  

  • 52. Fibrinolytic activity in blood and lungs of rats treated with monocrotaline pyrrole.
    Schultze AE; Roth RA
    Toxicol Appl Pharmacol; 1993 Jul; 121(1):129-37. PubMed ID: 7687795
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Effect of sodium heparin on activated fibrinolysis in the rat in vivo].
    Badimón L; Villaverde C; Badimón JJ; Vidal M; Valdecasas FG
    Arch Farmacol Toxicol; 1981 Apr; 7(1):105-8. PubMed ID: 7325697
    [No Abstract]   [Full Text] [Related]  

  • 54. Haemostatic effects of stanozolol in elderly medical patients.
    Small M; MacLean JA; McArdle BM; Bertina RM; Lowe GD; Forbes CD
    Thromb Res; 1984 Aug; 35(3):353-8. PubMed ID: 6547787
    [No Abstract]   [Full Text] [Related]  

  • 55. Increase of nonplasmin fibrinolytic activity in the lung and spleen of streptozotocin-induced diabetic rats.
    Okamoto U; Nagamatsu Y; Yamamoto J; Ikeda S; Kubota A
    Haemostasis; 1987; 17(3):154-61. PubMed ID: 3111954
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effect of fibrinolytic stimulation by stanozolol on postoperative pulmonary complications.
    Cuschieri RJ; Morran CG; Lowe GD; Blamey SL; Forbes CD; McArdle CS
    Haemostasis; 1985; 15(5):353-6. PubMed ID: 4076841
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Localization of fibrinolytic activity in the kidney and urinary tract of rats and rabbits.
    Myhre-Jensen O
    Lab Invest; 1971 Nov; 25(5):403-11. PubMed ID: 5136989
    [No Abstract]   [Full Text] [Related]  

  • 58. Proceedings: Study of the enhancement of fibrinolysis in an experimental animal.
    Gray LJ; Browse NL
    Br J Surg; 1974 Apr; 61(4):319-20. PubMed ID: 4832644
    [No Abstract]   [Full Text] [Related]  

  • 59. The fibrinolytic response to stanozolol in normal subjects.
    Preston FE; Burakowski BK; Porter NR; Malia RG
    Thromb Res; 1981 Jun 1-25; 22(5-6):543-51. PubMed ID: 6171045
    [No Abstract]   [Full Text] [Related]  

  • 60. Metformin and stanozolol in blood fibrinolytic activity.
    Menon IS
    Br Med J; 1971 Jan; 1(5743):289-90. PubMed ID: 5542166
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.